Trade

The USA, China and the WTO dispute

The dispute resolution panel’s decision in the USA’s complaint against China’s rules on enforcement, “Measures affecting the protection and enforcement of intellectual property rights” (DS362) (background here) has been published.

There’s a range of commentary around the web.  The  IPKat reproduces the conclusions and, applying sophistaKatted Euro reading between the lines, scores it at 3-all.

Intellectual Property Watch’s summary here.  According to the USTR, the US won.

Not sure what has happened to the “market access” dispute?

The USA, China and the WTO dispute Read More »

USA, China, Famous Brands and WTO

The USA has has commenced formal consultations – the first steps in another WTO complaint – in the WTO against the People’s Republic of China, alleging China is providing illegal protection for famous Chinese brands.

From the fact sheet:

China appears to be providing numerous WTO-illegal subsidies at multiple levels 

of government.  These include providing exporters: 

• Cash grant rewards for exporting 

• Preferential loans  

• Research and development funding  

• Cash grants to lower the cost of export credit insurance  

• The subsidies at issue offer significant benefits, particularly through cash grants that can reach over $400,000 to a single producer from a single level of government.

It would seem these are different “famous” brands to all those famous brands that are now “made in China”.

USTR press statement here.

USTR fact sheet here.

USA, China, Famous Brands and WTO Read More »

ACTA – December meeting

ACTA – December meeting Read More »

Pharmaceutical patents

The European Commission has published its preliminary report into its inquiry into the state of competition in the pharmaceutical industry in the EU – comment and links via IPKat.

The IPKat also has links to what they describe as “the powerful speech” delivered by Sir Robin Jacob (aka Jacob LJ) in the Commission’s public meeting on the issue.

Meanwhile, the developing countries are developing a proposal which envisages greater involvement of WHO; see here, while there are also reports of the Director General of the WTO appearing to acknowledge some significance to the issue.

Pharmaceutical patents Read More »

ACTA-phobes

The “gang” secretly negotiating ACTA (the Anti-Counterfeitng Treaty) is starting to attract increasingly organised opposition:

*  “100 groups” (ranging from the EFF in the USA to the Australian National University to …) have signed a “letter” challenging much of what is (assumed) to be going on behind closed doors

* China, supported by Brazil and India, amongst others, has launched a campaign to force ACTA back into WIPO

Of course, one might speculate that the developing countries or the “South” (in a non-US civil war sense) might feel they have better voting prospects in WIPO than, say, a treaty which is being negotiated without them by, apparently,  Australia, Canada, European Union, Japan, Jordan, Korea, Mexico, Morocco, New Zealand, Singapore, Switzerland, United States, and the United Arab Emirates.  Then again, one might wonder if that will dissuade the gang of 13 (if one may count the EU as “one”) from rushing headlong onwards?

ACTA-phobes Read More »

ACTA DownUnder

It seems DFAT has been considering ACTA since December 2007.

An overview here and here.

Now, DFAT has called for submissions and has flagged these as interesting topics.

Lid dip, Cheng Lim.

Meanwhile, IPKat reports of a UK Intellectual Property Office consultation paper on penalties for copyright infringement.

IPKat also draws attention to some further EU perspective on counterfeiting here (scroll down to 7.2).

ACTA DownUnder Read More »